Veradermics (NYSE:MANE – Get Free Report) was upgraded by equities researchers at Wall Street Zen from a “sell” rating to a “hold” rating in a research report issued on Sunday.
Several other equities research analysts also recently weighed in on MANE. Cantor Fitzgerald initiated coverage on Veradermics in a report on Monday, March 2nd. They set an “overweight” rating on the stock. Jefferies Financial Group assumed coverage on Veradermics in a report on Monday, March 2nd. They set a “buy” rating and a $75.00 price target on the stock. Needham & Company LLC assumed coverage on Veradermics in a report on Tuesday, June 2nd. They issued a “buy” rating and a $136.00 price objective on the stock. Zacks Research upgraded Veradermics to a “hold” rating in a report on Tuesday, March 3rd. Finally, Leerink Partners increased their price objective on Veradermics from $75.00 to $90.00 and gave the company an “outperform” rating in a report on Wednesday, April 22nd. Five analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $109.00.
Get Our Latest Stock Analysis on MANE
Veradermics Trading Up 1.6%
Veradermics (NYSE:MANE – Get Free Report) last issued its quarterly earnings results on Tuesday, May 12th. The company reported ($1.32) earnings per share for the quarter, missing the consensus estimate of ($0.56) by ($0.76).
Veradermics Company Profile
MANE is a global manufacturer and supplier of flavors, fragrances and ingredients for the food, beverage, personal care, household and fine fragrance markets. Headquartered in France, the company develops and produces aromatic solutions that are used by consumer goods companies, food processors, perfumers and formulators seeking sensory impact, taste modulation and olfactory character for their products.
The company’s product portfolio includes savory and sweet flavor systems, beverage concentrates, natural extracts, essential oils, fragrance compounds, cosmetic ingredients and specialty functional solutions such as taste enhancers and odor masking agents.
Featured Stories
- Five stocks we like better than Veradermics
- Time to Sell? 3 Winners With Fading Technical Momentum
- Why These 2 Hotel Stocks Are Beating Travel Peers
- This Energy Stock Has Quietly Soared 130% in a Year
- 3 ‘Boring’ Dividend Stocks With Tasty Technical Setups
Receive News & Ratings for Veradermics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradermics and related companies with MarketBeat.com's FREE daily email newsletter.
